BriaCell Therapeutics (BCTXF) News Today $0.65 -0.03 (-4.41%) (As of 11/12/2024 ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BriaCell Unveils Promising Cancer Therapy DataNovember 4, 2024 | markets.businessinsider.comBriaCell reports survival data from Phase 2 studyOctober 22, 2024 | msn.comBriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing ConcernsOctober 22, 2024 | seekingalpha.comBriaCell’s Bria-IMT Regimen Shows Promise for Metastatic Breast Cancer with Brain Metastasis: A Buy RecommendationOctober 3, 2024 | markets.businessinsider.comBriaCell Therapeutics Raises $8.5M After Positive Results for Experimental Cancer TherapySeptember 19, 2024 | msn.comBriaCell falls on $5M stock offeringMay 15, 2024 | msn.comBriaCell Therapeutics Corp Ordinary Shares - New BCTApril 21, 2024 | morningstar.comBriaCell’s Shareholders Approve Directors and AuditorsFebruary 2, 2024 | msn.comBriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast CancerJanuary 4, 2024 | finanznachrichten.deMiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual MeetingNovember 15, 2023 | businesswire.comBriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateOctober 25, 2023 | finance.yahoo.comOctober is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyOctober 20, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp flat on Monday (BCT)September 26, 2023 | theglobeandmail.comBriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing ThesisSeptember 10, 2023 | msn.comBriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast CancerSeptember 8, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. Announces Voting Results From Special MeetingAugust 18, 2023 | finance.yahoo.comBriaCell receives NCI grant for cancer platform developmentAugust 17, 2023 | msn.comBriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)July 22, 2023 | theglobeandmail.comBriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. WainwrightJune 28, 2023 | markets.businessinsider.comBriaCell Therapeutics in Definitive Agreement to Spin Off Certain AssetsMay 25, 2023 | marketwatch.comBriaCell to spin out BriaPro TherapeuticsMay 25, 2023 | msn.comBriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)April 27, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Thursday (BCT)April 7, 2023 | theglobeandmail.comToronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff PlansApril 1, 2023 | morningstar.comBriaCell Therapeutics to Spin Off Certain AssetsMarch 30, 2023 | marketwatch.comBriaCell Sees Positive Survival Data in Ongoing TrialFebruary 23, 2023 | marketwatch.comBriaCell Reports Positive Survival Data in Advanced Metastatic Breast CancerFebruary 23, 2023 | finance.yahoo.comBriaCell to Investigate Potential Stock ManipulationJanuary 23, 2023 | marketwatch.comBriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost EnrolmentJanuary 12, 2023 | stockhouse.comBriaCell to get US, Australian patent linked to personalized cancer immunotherapyJanuary 10, 2023 | msn.comBriaCell signs exclusive licensing deal with UMBC for cancer treatment candidateAugust 5, 2022 | bizjournals.comBriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this yearJuly 21, 2022 | finance.yahoo.comBriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer ImmunotherapyJuly 5, 2022 | nz.finance.yahoo.comWe're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash WiselyMay 6, 2022 | nz.finance.yahoo.comWhy BriaCell Therapeutics Stock Is Surging TodayApril 13, 2022 | msn.comBriaCell gains on FDA fast track nod for its targeted breast cancer immunotherapy Bria-IMTApril 13, 2022 | seekingalpha.comWhy BriaCell Therapeutics Is Rising In Pre-market?April 13, 2022 | nasdaq.comBriaCell Adds Two Clinical Trial Sites to Accelerate Patient EnrollmentFebruary 28, 2022 | finance.yahoo.comBriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of ShareholdersJanuary 19, 2022 | nz.finance.yahoo.comBriaCell Moves Forward to Initiate Phase I/IIa Clinical Study for BriaVax(TM) in Advanced Breast CancerOctober 26, 2021 | finance.yahoo.comBriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.comSeptember 23, 2021 | finance.yahoo.comBriaCell Announces TSXV Acceptance of Normal Course Issuer BidSeptember 22, 2021 | finance.yahoo.comBriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed WarrantsSeptember 9, 2021 | finance.yahoo.comBriaCell Therapeutics Appoints Marc Lustig to its Board of DirectorsSeptember 1, 2021 | finance.yahoo.comBriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in ...August 20, 2021 | apnews.comBRIEF-Briacell Therapeutics Says Will Voluntarily Delist Its Common Shares From Trading On Frankfurt Stock Exchange Effective August 19August 17, 2021 | msn.comL5 Capital Announces Acquisition of Common Shares of BriaCell Therapeutics Corp.August 6, 2021 | finance.yahoo.com Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here BCTXF Media Mentions By Week BCTXF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTXF News Sentiment▼0.000.60▲Average Medical News Sentiment BCTXF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTXF Articles This Week▼00▲BCTXF Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Salarius Pharmaceuticals News Today Dermata Therapeutics News Today Galmed Pharmaceuticals News Today Emmaus Life Sciences News Today Onconetix News Today Oragenics News Today Altamira Therapeutics News Today Trevena News Today Bon Natural Life News Today Peak Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BCTXF) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
